Table 2. Factors associated with active TB occurrence among HIV infected children in Ethiopia.
Variables | OR | 95%CI | I2 | Q2 | P value of Q | P value of estimation |
---|---|---|---|---|---|---|
Advanced WHO Clinical stages | Ref | Ref | Ref | Ref | < 0.001 | |
Stages I&II | ||||||
Stage III&IV | 2.27 | [1.18–2.73] | 89.5% | 0.99 | 0.001 | |
Cotrimoxazole preventive therapy (CPT) | Ref | Ref | Ref | < 0.001 | ||
Given | ||||||
Not given | 4.26 | [3.47–5.28] | 43.3% | 2.99 | 0.116 | |
Isoniazid preventive therapy status (IPT) | Ref | Ref | Ref | < 0.001 | ||
Given | ||||||
Not Given | 2.28 | [1.99–3.18] | 38.8% | 2.07 | 0.22 | |
Level of Hemoglobin Hgb ≤ 10 gm/dl | 3.11 | (1.57–4.7 | 77.6% | 3.11 | < 0.001 | |
Hgb > 10 gm/dl | Ref |
Hgb = hemoglobin, IPT = Isoniazid preventive therapy status (IPT), Cotrimoxazole preventive therapy (CPT)